- About
- Projects
- Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
- Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
- Column 1
- News and Events
- Expanded Access eRequest
Past Events
In recent months, scientists and policymakers around the globe have rallied together with one common goal: to eliminate Covid-19.
Trust is health’s most valuable player
COVID-19 has made clear that the
December 17, 2020 (Washington, D.C.) As Americans patiently await their turn for COVID-19 vaccination, a group of leading medical, health equity and public policy experts discussed and an
US regulators have authorised the first coronavirus vaccine for emergency use, marking an inflection point in the
On a hot afternoon in August, Debbie Honeycutt walked into the crowded waiting room of the Medical Center for Clinical Research, an experimental-treatment facility tucked inside a squat office building in San Diego.
NEW YORK, Dec. 9, 2020 /PRNewswire/ -- The Michael J.
Tom Skelton, CEO of Surescripts, recently spoke with Dr. Amy Abernethy of the FDA, about the impact of COVID-19 and the evolving data needs of public health.
Honorees to be recognized virtually on December 8, 2020
ZURICH/LONDON (Reuters) - With COVID-19 vaccine trial results looking positive, governments and pharmaceutical firms face their next daunting challenge: convincing the world to get inoculated.
Reagan-Udall receives $250,000 from Rockefeller Foundation for COVID-19 Diagnostics Evidence Accelerator